BCL2L1 and AL amyloidosis: In a xenograft mouse model of multiple myeloma and BCL‐2, ABT‐263 exhibited increased toxicity when mice were treated with the BCL‐2, BCL‐XL, and BCL‐W inhibitor ABT‐263 (Tse et al., 2008).